Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines

Clinical Cancer Research

Volumn 5, Issue 3, 1999, Pages 493-499

  Schumacher, Guido ^a   Kataoka, Masafumi ^b   Roth, Jack A ^c,d   Mukhopadhyay, Tapas ^c,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; CD31 ANTIGEN; ESTROGEN; PROTEIN P53;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL COUNT; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032994838     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Gelbke, H. P., and Knuppen, R. The excretion of five different 2-hydroxyoestrogen monomethyl ethers in human pregnancy urine. J. Steroid Biochem., 7: 457-463, 1976.
2. Fotsis, T., Zhang, Y., Pepper, M. S., Adlercreutz, H., Montesano, R., Nawroth, P. P., and Schwelgerer, L. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature (Lond.), 368: 237-239, 1994.
3. Zhu, B. T., and Conney, A. H. Is 2-Methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res., 58: 2269-2277, 1998.
4. Mukhopadhyay, T., and Roth, J. A. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene, 14: 379-384, 1997.
5. Raff, M. C., Barres, B. A., Burne, J. F., Coles, H. S., Ishizaki, Y., and Jacobson, M. D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science (Washington DC), 262: 695-700, 1993.
6. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
7. Vaux, D. L., and Strasser, A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA, 93: 2239-2244, 1996.
8. Yue, T. L., Wang, X., Louden, C. S., Gupta, S., Pillarisetti, K., Gu, J. L., Hart, T. K., Lysko, P. G., and Feuerstein, G. Z. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol. Pharmacol., 51: 951-962, 1997.
9. Mukhopadhyay, T., and Roth, J. A. Superinduction of wild-type p53 protein after 2-methoxyestradiol treatment of Ad5p53-transduced cells induces tumor cell apoptosis. Oncogene, 17: 241-246, 1998.
10. Elsasser, H. P., Lehr, U., Agricola, B., and Kern, H. F. Establishment and characterization of two cell lines with different grades of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch., 61: 295-306, 1992.
11. Elsasser, H. P., Lehr, U., Agricola, B., and Kern, H. F. Structural analysis of a new highly metastatic cell line PaTu 8902 from a primary human pancreatic adenocarcinoma. Virchows Arch., 64: 201-207, 1993.
12. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W. W., Owen-Schaub, L. B., and Roth, J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenoviral-mediated transfer of the wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994.
13. Chen, X., Ko, L. J., Jayaraman, L., and Prives, C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev., 10: 2438-2451, 1996.
14. Ronen, D., Schwartz, D., Teitz, Y., Goldfinger, N., and Rotter, V. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ., 7: 21-30, 1996.
15. Merriam, G. R., MacLusky, N. J., Picard, M. K., and Naftolin, F. Comparative properties of the catechol estrogens. I. Methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors. Steroids, 36: 1-11, 1980.
16. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
17. Fan, T. P., Jaggar, R., and Bicknell, R. Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol. Sci., 16: 57-66, 1995.
18. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
19. Tishler, R. B., Lamppu, D. M., Park, S., and Price, B. D. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res., 55: 6021-6025, 1995.
20. Attalla, H., Makela, T. P., Adlercreutz, H., and Andersson, L. C. 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem. Biophys. Res. Commun., 228: 467-473, 1996.
21. Seegers, J. C., Lottering, M. L., Grobler, C. J. S., Vanpapendorf, D. H., Habbersett, R. C., Shou, Y. L., and Lehnen, B. E. The mammalian metabolite, 2-methoxyestradiol, affects p53 levels and apoptosis induction in transformed cells but not in normal cells. J. Steroid Biochem. Mol. Biol., 62: 253-267, 1997.